Free Trial
NASDAQ:INBS

Intelligent Bio Solutions Q2 2025 Earnings Results & Report

Intelligent Bio Solutions logo
$1.38 -0.11 (-7.09%)
As of 11:20 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Intelligent Bio Solutions reported Q2 2025 earnings on February 13, 2025. The company reported EPS of -$5.00, while revenue was $610.00 billion.

Earnings Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call
7:00 AM ET

Intelligent Bio Solutions EPS Results

Actual EPS
-$5.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
1 of last 6 quarters

Intelligent Bio Solutions Revenue Results

Actual Revenue
$610.00 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Intelligent Bio Solutions' Q1 2027 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedules, with a conference call scheduled on Monday, November 9, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Intelligent Bio Solutions Q2 2025 Earnings FAQ

Intelligent Bio Solutions (NASDAQ:INBS) reported earnings of -$5.00 per share for Q2 2025. The report was announced on Thursday, February 13, 2025.

Intelligent Bio Solutions reported revenue of $610.00 billion for Q2 2025.

Intelligent Bio Solutions' next earnings date is estimated for Wednesday, November 11, 2026. MarketBeat tracks confirmed and estimated earnings dates for Intelligent Bio Solutions on the company's earnings history page.

Intelligent Bio Solutions Earnings Headlines

I have publicly predicted six major American crashes, before each one happened.
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
See More Intelligent Bio Solutions Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Intelligent Bio Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intelligent Bio Solutions and other key companies, straight to your email.

About Intelligent Bio Solutions

Intelligent Bio Solutions (NASDAQ:INBS) is a life sciences company developing rapid, non-invasive drug-screening technologies. Its primary product is the Intelligent Fingerprinting Drug Screening System, which analyzes sweat collected from a person’s fingerprint to identify the presence of commonly used drugs.

The system combines a disposable drug-screening cartridge with a portable reader and associated software. By using fingerprint sweat rather than blood or urine, the company aims to provide a convenient testing option for organizations such as employers, law-enforcement agencies, drug-treatment providers and other healthcare or public-sector users.

Intelligent Bio Solutions has roots in the development of diagnostic technologies and was formerly known as GBS Inc. The company markets its fingerprint-based screening products internationally, including in the United Kingdom and other markets, subject to applicable regulatory and commercial requirements. The company is led by Chief Executive Officer Harry Simeonidis.

View Intelligent Bio Solutions Profile